Skip to content

Physical therapy and nutritional management for patients with esophageal cancer treated with chemoradiotherapy

Physical therapy and nutritional management for patients with esophageal cancer treated with chemoradiotherapy

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT1050250067
Enrollment
25
Registered
2025-07-14
Start date
2025-08-20
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal cancer

Interventions

Physical therpay and nutritional management

Sponsors

Sakanaka Katsuyuki
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) 18 years of age or older 2) ECOG performance status 0-2 3) Histologically diagnosed with esophageal cancer 4) Clinical stage Stage I-IVA (UICC TNM 8th edition) 5) Scheduled to receive chemoradiation therapy with a total dose of 50 Gy or more 6) Dysphagia score of 2 or less 7) Maintaining upright position for 3 minutes

Exclusion criteria

Exclusion criteria: 1) History of surgery on the esophagus (excluding endoscopic treatment) 2) Implanted pacemaker or cardioverter-defibrillator 3) Uncontrolled diabetes 4) Systemic infection requiring systemic treatment 5) Pregnant or possibly pregnant 6) Determined by the principal investigator or co-investigator to be unsuitable for participation in this study

Design outcomes

Primary

MeasureTime frame
The proportion of patients with a change in skeletal muscle index of less than 8% between before and 12 weeks after chemoradiotherapy.

Secondary

MeasureTime frame
1) Physical function 2) Physical therapy implementation status and nutritional intake status 3) Proportion of patients requiring peripheral intravenous nutrition 4) Proportion of patients requiring central intravenous nutrition 5) Proportion of patients requiring enteral nutrition 6) Bowel movement status 7) Proportion of patients with acute adverse event 8) Proportion of patients who completed hemoradiotherapy 9) Overall survival, progresion free survival, and loco-regional control

Contacts

Public ContactShinya Hiraoka

Kyoto University Hospital

shiraok@kuhp.kyoto-u.ac.jp+81-75-751-3762

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026